PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.09
ESG score 90-95% of Healthcare median of 62.81. John Neff would demand higher returns to compensate for below-average ESG risk management.
56.82
Environmental score near Healthcare median of 58.92. David Dodd would investigate if industry-standard environmental practices adequately address climate risks.
57.54
Social score 80-90% of Healthcare median of 64.46. Martin Whitman would look for hidden social liabilities and reputational risks.
59.92
Governance score 90-95% of Healthcare median of 64.14. John Neff would demand higher returns to compensate for below-average governance oversight.